INS and metabolic dysfunction-associated steatotic liver disease: In this study, NAFLD- MAFLD + patients had statistically higher blood pressure, BMI, waist circumference, NFS, and abnormal glucose metabolism (e.g., fasting glucose, fasting insulin, glycosylated hemoglobin, insulin resistance index).